Healthcare Pharmaceutical Biotech

Licensed Agents and Insurance Agencies Can Now Run Their Entire Practice from a Single AI-Powered Insurance Platform at No Upfront Cost

April 17, 2026 10:00 AM

Starting today, licensed agents and agencies contracted with MPA can quote Medicare Advantage, Supplement, and Part D plans, access over 17 life insurance products from Final Expense to Whole Life, generate and receive AI-scored leads, enroll clients, monitor compliance across all 50 states, track commissions across every carrier, and manage post-sale retention from a single login, at no upfront cost. The product is called MPA. It is live now at...

Read more

Understanding Autism Today-and How Care Is Evolving

April 17, 2026 9:00 AM

Key points Autism Spectrum Disorder (ASD), more commonly referenced only as autism is a lifelong condition and exists on a spectrum, with varying degrees of symptoms and impacts. Cases are being identified more often today mostly because we've gotten better at recognizing, understanding and diagnosing it. And the industry has expanded the conditions that fall on the spectrum. There's no single right way to support someone with autism. Care works...

Read more

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo

April 17, 2026 8:00 AM

Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary, Buzz Bomb Caffeine Company, is proud to announce that elite ultra-marathoner and BUZZ BOMB™ Global Brand Ambassador Ashley Paulson will attempt to shatter the female world record for the fastest 100-mile treadmill run. The historic attempt will take place live at the Boston Marathon Expo at the John B. Hynes Veterans Memorial Convention Center on...

Read more

Conference Call on Interim Report January-March 2026

April 17, 2026 8:00 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report January-March 2026. The presentation will be held in English. Time: April 24 at 2.00 pm CET / 8.00 am EST If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions. https://events.inderes.com/xvivo/q1-report-2026 If you wish to participate via teleconference...

Read more

Zide Door Marks 4/20 with Community Offerings and Salute to Psilocybin History

April 17, 2026 6:30 AM

Most people recognize 4/20 as a day on the calendar tied to cannabis culture. Many in psychedelic culture also recognize 4/19 as Bicycle Day, the anniversary of Albert Hofmann's first intentional LSD experience. But far fewer know that April 20 is also the anniversary of the Marsh Chapel Experiment, the landmark 1962 Good Friday psilocybin study at Boston University that helped establish the modern connection between psychedelics, mystical...

Read more

Invitation to Presentations of Senzime's First Quarter 2026 Report

April 17, 2026 4:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to presentations of the first quarter report for 2026 on April 22. The report will be published at 08.00 am CEST the same day. Philip Siberg, CEO of Senzime, will present the Q1 report through a webcast that can be seen from 09.00 am CEST on Senzime's website https://www.senzime.com/investors A Live Q&A, hosted by Gustaf Meyer, analyst at Redeye, will be aired at...

Read more

Nomination Committee's proposal to the Board of Directors for IRLAB Therapeutics' Annual General Meeting 2026

April 17, 2026 4:10 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the Nomination Committee proposes the election of Jan‑Fredrik Backman as new Vice Chairperson and James Gamgort as new Board member at the Annual General Meeting in 2026. The Nomination Committee further proposes the re‑election of Chairperson Carola Lemne and Board members Gunnar Olsson, Rein Piir...

Read more

Cantargia Publishes Annual Report 2025

April 17, 2026 1:50 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA) today announced that the annual report for 2025 has been published. The Annual Report is attached to this press release and is available on the company's website, www.cantargia.com. "2025 was a transformational year for Cantargia. We secured commercial validation of our IL1RAP platform through a major partnership with Otsuka Pharmaceutical, achieved FDA Fast Track Designation for nadunolimab in our...

Read more

Notice of Annual General Meeting in Cantargia AB (publ)

April 17, 2026 1:50 AM

Cantargia (STO:CANTA) - The shareholders of Cantargia AB (publ), reg. no. 556791-6019, are invited to the annual general meeting on Thursday, 21 May 2026, at 15.00 CEST at Ideon Gateway, Scheelevägen 27, Lund, Sweden. Right to participate and notice Participation at the venue Shareholders who wish to participate in the meeting at the venue in person or represented by a proxy must: be recorded in the share register maintained by Euroclear Sweden...

Read more

At White House Summit, Rhombus and East County Transitional Living Center CEO Pushes for Structured Continuum Care

April 16, 2026 6:15 PM

Julie Hayden, Psy.D, practiced her passion recently, presenting methods for helping battle drug addiction, mental health problems and homelessness during a special White House meeting April 13 - 14, 2026. Hayden, a psychologist and community advocate who is chief executive officer and executive director of Rhombus University, Rhombus Counseling, La Mesa Counseling, New Vision Counseling Center, Genesis Recovery and East County Transitional...

Read more

Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale

April 16, 2026 5:32 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic solutions for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, April 24, 2026 at 4:00 p.m. Eastern Time. The April program, titled "Fourth Friday at Four - Built to Perform: Inside Zomedica's Manufacturing and Quality...

Read more

MMJ International Holdings Seeks Federal Preliminary Injunction May 1 to Halt CMS Hemp-CBD Medicare Pilot

April 16, 2026 5:25 PM

MMJ International Holdings, Inc. today confirmed it has joined federal litigation challenging the Centers for Medicare & Medicaid Services' ("CMS") Substance Access Beneficiary Engagement Incentive (BEI) program and is seeking a preliminary injunction and stay of agency action ahead of a scheduled May 1, 2026 federal court hearing in the United States District Court for the District of Columbia. MMJ International Holdings and its subsidiaries...

Read more

American College of Osteopathic Family Physicians Conclave of Fellows Welcomes 2026 Class

April 16, 2026 5:00 PM

The American College of Osteopathic Family Physicians (ACOFP) Conclave of Fellows honored seventeen physicians with the designation of Fellow of the ACOFP and one with the designation of Distinguished Fellow of the ACOFP during its 63rd Annual Convention & Scientific Seminars in Orlando, Florida. The designation of Fellow is bestowed upon candidates who have contributed outstanding national and local service through teaching, authorship,...

Read more

Protagonist Therapeutics Reports Granting of Inducement Awards

April 16, 2026 4:05 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on April 15, 2026, it issued inducement awards to two recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022. The new employees received, in the aggregate, options to...

Read more

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

April 16, 2026 3:15 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the continued integration of artificial intelligence (AI) across its operations, reflecting ongoing investments aimed at enhancing efficiency, reducing costs, improving customer experience, and driving sales growth. AI is becoming an increasingly important component of Cosmos Health's operating model...

Read more

Greater Canal Efficiency. Less Waste. Introducing ZenSeal(TM) Pro with ZenSave(TM) Tips from Kerr Dental

April 16, 2026 2:30 PM

Kerr Dental announced the launch of NEW ZenSeal Pro with ZenSave Tips, an innovative advancement in bioceramic (BC) sealer delivery, engineered to help clinicians treat more canals with every syringe, while maintaining the high performance and clinical confidence they expect. Building on the trusted performance of ZenSeal™ Plus BC sealer, ZenSeal Pro takes efficiency and handling even further-so if you love ZenSeal, you'll love ZenSeal Pro even...

Read more

New National Survey Reveals the Full Impact of Living with Sjögren's Disease

April 16, 2026 2:00 PM

Today, the Sjögren's Foundation released new findings from its most recent Living with Sjögren's® patient survey, offering the most comprehensive look to date at self-reported experiences of people living with Sjögren's disease. The findings show that Sjögren's disease goes far beyond dryness, with relentless, wide-ranging symptoms that notably impact daily life, work, and overall well-being. The survey, conducted online by the Sjögren's...

Read more

Kerr Dental Launches Demi(TM) Pro - The Light That Moves With You

April 16, 2026 1:00 PM

Kerr Dental announces the launch of Demi Pro, a new cordless curing light designed to deliver dependable, uniform curing performance with reduced fatigue and improved access - even in challenging anatomies. Engineered for both dentists and dental assistants, Demi Pro supports modern restorative workflows through a balance of ergonomics, optical performance, and intuitive safety features. Ergonomics: Built for All-Day Comfort Demi Pro features a...

Read more

The Longevity Centers of America Offers $175 Risk-Free Initial Consultation for New Patients

April 16, 2026 10:00 AM

The Longevity Centers of America (LCOA) is spreading awareness about its low-cost integrative medicine consultation, which increases access to longevity care for individuals starting at square one of their integrative or functional health journey. The longevity medicine consultation is physician-supervised and an ideal choice for those with chronic health concerns who want a guided, low-pressure starting point to integrative and/or functional...

Read more

Medical Care Technologies (OTC PINK:MDCE) Reaffirms Commitment to AI-Driven Medical Innovation Following Successful Consumer App Launch

April 16, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology-driven innovator in artificial intelligence and healthcare solutions, today reaffirmed its strategic commitment to advancing its core AI-powered medical research initiatives following the successful launch and early traction of its consumer-facing mobile application, Snapshot Recipes. Over the past several months, the Company has successfully demonstrated...

Read more